Clinical Trial Update: Specific Use-Result of Spiriva Respimat® in Asthmatics

View source ↗

Summary

A completed clinical trial evaluating Spiriva Respimat in asthmatics with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SPIRIVA RESPIMAT (tiotropium bromide inhalation spray)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Status: COMPLETED | Results posted: 2019-11-27